Advertisement
Advertisement

Exor completes PartnerRe sale, bolsters coffers for acquisitions

By:
Reuters
Published: Jul 12, 2022, 18:53 UTC

MILAN (Reuters) - Exor said on Tuesday it had completed the sale of reinsurer PartnerRe to France's Covea, providing a multibillion-euro warchest for acquisitions for the holding company of Italy's Agnelli family.

Fiat Chairman Elkann attends investors day held by holding group in Turin

MILAN (Reuters) – Exor said on Tuesday it had completed the sale of reinsurer PartnerRe to France’s Covea, providing a multibillion-euro warchest for acquisitions for the holding company of Italy’s Agnelli family.

Exor said in a statement it would receive $9.3 billion in cash for the sale of the Bermuda-based firm, a deal that had previously been derailed by the coronavirus pandemic.

The two parties earlier this year agreed to increase the selling price by around $300 million, from an initial $9 billion, based on PartnerRe’s performance in 2021.

Exor CEO John Elkann said in November Exor would have about 9 billion euros ($9.1 billion) available for investments including in luxury, healthcare and technology industries, once it completed the PartnerRe sale.

Those include the purchase of a 10% stake in French healthcare group Institut Merieux for 833 million euros that Exor announced earlier this month.

Exor, whose main investments include carmakers Stellantis and Ferrari and soccer club Juventus, said on Tuesday that, as previously agreed, it would continue its cooperation with Covea.

($1 = 0.9933 euros)

(Reporting by Giulio Piovaccari; Editing by Keith Weir and Mark Potter)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement